Slashing the timelines: Opting to generate high‐titer clonal lines faster via viability‐based single cell sorting

Chinese hamster ovary (CHO) cell line development (CLD) is a long and laborious process, which requires up to 5 − 6 months in order to generate and bank CHO lines capable of stably expressing therapeutic molecules. Additionally, single cell cloning of these production lines is also necessary to confirm clonality of the production lines. Here we introduce the utilization of viability staining dye in combination with flow cytometer to isolate high titer clones from a pool of selected cells and single cell deposit them into the wells of culture plates. Our data suggests that a stringent selection procedure along with viability dye staining and flow cytometry‐based sorting can be used to isolate high expressing clones with titers comparable to that of traditional CLD methods. This approach not only requires less labor and consumables, but it also shortens CLD timelines by at least 3 weeks. Furthermore, single cell deposition of selected cells by a flow sorter can be regarded as an additional clonality assurance factor that in combination with Day 0 imaging can ensure clonality of the production lines. © 2015 American Institute of Chemical Engineers Biotechnol. Prog., 32:198–207, 2016

[1]  P. Sharp,et al.  Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene. , 1982, Journal of molecular biology.

[2]  J. Weaver,et al.  Gel Microdroplets and Flow Cytometry: Rapid Determination of Antibody Secretion by Individual Cells Within a Cell Population , 1990, Bio/Technology.

[3]  James C. Weaver,et al.  Rapid Clonal Growth Measurements at the Single-Cell Level: Gel Microdroplets and Flow Cytometry , 1991, Bio/Technology.

[4]  G. M. Lee,et al.  Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[5]  M. Al-Rubeai,et al.  Improved cell line development by a high throughput affinity capture surface display technique to select for high secretors. , 1999, Journal of immunological methods.

[6]  Y G Meng,et al.  Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells. , 2000, Gene.

[7]  D. Drapeau,et al.  Adaptation of mammalian cells to growth in serum-free media , 2000, Molecular biotechnology.

[8]  A. Dickson,et al.  Characterization of the stability of recombinant protein production in the GS-NS0 expression system. , 2001, Biotechnology and Bioengineering.

[9]  Noelle-Ann Sunstrom,et al.  High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein. , 2002, Biotechnology and bioengineering.

[10]  G. Chiang,et al.  A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. , 2003, Journal of immunological methods.

[11]  Mohamed Al-Rubeai,et al.  The selection of high-producing cell lines using flow cytometry and cell sorting , 2004, Expert opinion on biological therapy.

[12]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[13]  R. J. Sleiman,et al.  Accelerated cell line development using two‐color fluorescence activated cell sorting to select highly expressing antibody‐producing clones , 2008, Biotechnology and bioengineering.

[14]  B. Snedecor,et al.  Chinese hamster ovary K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11‐derived dihydrofolate reductase deficient host cell , 2013, Biotechnology progress.

[15]  B. Snedecor,et al.  It's time to regulate: Coping with product‐induced nongenetic clonal instability in CHO cell lines via regulated protein expression , 2014, Biotechnology progress.